CN Patent

CN1266144C — 黄芩甙和黄芩甙元的用途和剂型

Assigned to Kaihui Pharmaceutical Shanghai Co ltd · Expires 2006-07-26 · 20y expired

What this patent protects

本发明公开了黄芩甙和黄芩甙元的用途和剂型，该类化合物具有如下结构：见右式，用于预防、治疗纤维化和硬化症组织修复还可潜在性去除已形成的纤维化的包含胶原质的组织。

USPTO Abstract

本发明公开了黄芩甙和黄芩甙元的用途和剂型，该类化合物具有如下结构：见右式，用于预防、治疗纤维化和硬化症组织修复还可潜在性去除已形成的纤维化的包含胶原质的组织。

Drugs covered by this patent

Patent Metadata

Patent number: CN1266144C
Jurisdiction: CN
Classification: —
Expires: 2006-07-26
Drug substance claim: No
Drug product claim: No
Assignee: Kaihui Pharmaceutical Shanghai Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.